Print

UBI HIV-1 MN China

Phase I trial of an HIV-1 synthetic peptide vaccine evaluating an accelerated immunization schedule in Yunnan, China.

Trial Details:

I Completed
UBI United Biomedical Inc. January 01, 1993
UBI HIV-1 Peptide Immunogen, Multivalent
UBI HIV-1 Peptide Immunogen, Multivalent Protein
China 29